Development of anti-NXP2 dermatomyositis following Comirnaty COVID-19 vaccination
Postgrad Med J
.
2022 Feb 7;postgradmedj-2022-141510.
doi: 10.1136/postgradmedj-2022-141510.
Online ahead of print.
Authors
Adrian Y S Lee
1
2
3
,
Caroline Lee
4
,
David A Brown
4
2
3
,
Dan Suan
4
3
Affiliations
1
Westmead Hospital, Westmead, New South Wales, Australia adrian.lee1@health.nsw.gov.au.
2
Department of Immunopathology, Institute for Clinical Pathology and Medical Research & NSW Health Pathology, Westmead, NSW, Australia.
3
Westmead Clinical School, The University of Sydney, Westmead, NSW, Australia.
4
Westmead Hospital, Westmead, New South Wales, Australia.
PMID:
35131890
DOI:
10.1136/postgradmedj-2022-141510
No abstract available
Keywords:
adult dermatology; immunology; neurology; rheumatology.